Three-dimensional biomimetic tissue scaffolds, as well as methods of manufacture of these scaffolds.

Additionally, methods of making the tissue scaffolds are provided.

According to some aspects, supports are provided for producing artificial tissue scaffolds.

The radio-opaque cross-linked polymer tissue scaffolds can assist in the targeting of radiation therapy.

According to some aspects, tissue scaffolds are provided that comprise one or more types of nanofibers.

The present invention provides engineered tissue scaffolds, engineered tissues, and methods of using them.

The use of suckerin proteins to produce fibres, films and tissue scaffolds is also described.

Also described are devices for treating wounds and methods of treating wounds using tissue scaffolds.

Methods for production and use of these tissue scaffolds in treatment o musculoskeletal tissue injuries are also provided.

The tissue scaffolds may be able to form a stable, three-dimensional shape in situ and elicit a limited immunologic or inflammatory response.

Use of IRE thus permits preparation of thick tissue scaffolds and tissues due to the presence of vasculature within the scaffolds.

A novel method of manufacturing thick foams, especially molded thick foams useful as tissue scaffolds and other medical devices.

The methods, mixtures, and kits can include an acellular tissue matrix, a polymer, and a solvent and may be capable of producing tissue scaffolds.

Provided are tissue scaffolds colonized by vertebrate cells expressing a transgenic bioactive molecule, where the vertebrate cells are unable to undergo mitosis.

Also provided are methods of growing tissue in a mammal and methods of delivering a transgenic bioactive molecule to a tissue of a mammal, using the tissue scaffolds.

Biodegradable, bioabsorhahie cross-linked polymer tissue scaffolds for filling a void in human or animal soft tissue, such as a surgical or other wound, are disclosed.